UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
10.64
-0.07 (-0.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
UroGen Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -115.38 | -102.24 | -109.78 | -110.82 | -128.48 | -105.15 | Upgrade
|
| Depreciation & Amortization | 1.3 | 1.71 | 1.82 | 1.77 | 2.04 | 1.32 | Upgrade
|
| Other Amortization | 1.01 | 1.01 | 1.75 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.97 | -1.03 | -0.5 | 0.48 | 0.44 | -0.57 | Upgrade
|
| Stock-Based Compensation | 12.42 | 9.34 | 10.58 | 23.11 | 28.03 | 29.97 | Upgrade
|
| Other Operating Activities | 8.51 | 10.52 | 13.75 | 13.67 | -1.54 | -0.91 | Upgrade
|
| Change in Accounts Receivable | -9.96 | -2.74 | -0.99 | -4.67 | -7.05 | - | Upgrade
|
| Change in Inventory | -2.59 | -1.35 | -0.36 | -2.87 | -1.96 | - | Upgrade
|
| Change in Accounts Payable | 5.6 | 4.16 | 0.28 | 2 | -1.25 | 2.93 | Upgrade
|
| Change in Income Taxes | 0.18 | 0.18 | 0.18 | 0.13 | 2.72 | - | Upgrade
|
| Change in Other Net Operating Assets | 4.73 | 4.08 | -4.29 | -7.69 | 1.17 | 1.39 | Upgrade
|
| Operating Cash Flow | -96.14 | -76.38 | -87.56 | -84.89 | -105.89 | -71.02 | Upgrade
|
| Capital Expenditures | -0.24 | -0.19 | -0.25 | -0.75 | -1.22 | -0.33 | Upgrade
|
| Investment in Securities | -92.34 | -0.76 | 1.31 | 4.82 | 94.45 | -145.1 | Upgrade
|
| Other Investing Activities | - | - | - | - | - | -0.17 | Upgrade
|
| Investing Cash Flow | -92.58 | -0.95 | 1.06 | 4.07 | 93.24 | -145.59 | Upgrade
|
| Long-Term Debt Issued | - | - | 95.78 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 24.49 | - | 95.78 | - | - | - | Upgrade
|
| Issuance of Common Stock | 153.75 | 70.52 | 1.51 | 72.46 | 16.59 | 165.33 | Upgrade
|
| Other Financing Activities | 16.35 | 46.41 | -0.16 | -0.14 | -0.07 | -0.08 | Upgrade
|
| Financing Cash Flow | 194.59 | 116.93 | 97.13 | 72.32 | 16.53 | 165.25 | Upgrade
|
| Net Cash Flow | 5.87 | 39.6 | 10.64 | -8.5 | 3.88 | -51.36 | Upgrade
|
| Free Cash Flow | -96.38 | -76.57 | -87.81 | -85.64 | -107.1 | -71.34 | Upgrade
|
| Free Cash Flow Margin | -107.85% | -92.57% | -136.45% | -178.27% | -907.71% | -396344.44% | Upgrade
|
| Free Cash Flow Per Share | -2.58 | -2.66 | -3.85 | -3.83 | -4.92 | -3.48 | Upgrade
|
| Levered Free Cash Flow | -49.25 | -34.14 | -42.79 | -44.14 | -55.94 | -33.66 | Upgrade
|
| Unlevered Free Cash Flow | -42.63 | -25.96 | -39.27 | -44.14 | -55.94 | -33.66 | Upgrade
|
| Change in Net Working Capital | 3.79 | -4.14 | 2.01 | 10.59 | 9.71 | -3.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.